AUTHOR=Shevtsov Maxim , Multhoff Gabriele 

TITLE=Immunological and Translational Aspects of NK Cell-Based Antitumor Immunotherapies

JOURNAL=Frontiers in Immunology

VOLUME=7

YEAR=2016

URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2016.00492

DOI=10.3389/fimmu.2016.00492

ISSN=1664-3224

ABSTRACT=<p>Natural killer (NK) cells play a pivotal role in the first line of defense against cancer. NK cells that are deficient in CD3 and a clonal T cell receptor (TCR) can be subdivided into two major subtypes, CD56<sup>dim</sup>CD16<sup>+</sup> cytotoxic and CD56<sup>bright</sup>CD16<sup>−</sup> immunoregulatory NK cells. Cytotoxic NK cells not only directly kill tumor cells without previous stimulation by cytotoxic effector molecules, such as perforin and granzymes or <italic>via</italic> death receptor interactions, but also act as regulatory cells for the immune system by secreting cytokines and chemokines. The aim of this review is to highlight therapeutic strategies utilizing autologous and allogenic NK cells, combinations of NK cells with monoclonal antibodies to induce antibody-dependent cellular cytotoxicity, or immune checkpoint inhibitors. Additionally, we discuss the use of chimeric antigen receptor-engineered NK cells in cancer immunotherapy.</p>